111 related articles for article (PubMed ID: 11760371)
21. [Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences].
Roznovský L; Orságová I; Petrousová L; Mrázek J; Kloudová A; Kabieszová L; Kůrková J; Pospísek M
Klin Mikrobiol Infekc Lek; 2010 Apr; 16(2):73-5. PubMed ID: 20503159
[TBL] [Abstract][Full Text] [Related]
22. Thymosin alpha 1 in combination with interferon alpha and ribavirin in chronic hepatitis C patients who are non-responders or relapsers to interferon alpha plus ribavirin.
Abbas Z; Hamid SS; Tabassum S; Jafri W
J Pak Med Assoc; 2004 Nov; 54(11):571-4. PubMed ID: 15623184
[TBL] [Abstract][Full Text] [Related]
23. High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial.
Fontana RJ; Walsh J; Moyer CA; Lok AS; Webster S; Klein S
J Clin Gastroenterol; 2002 Feb; 34(2):177-82. PubMed ID: 11782615
[TBL] [Abstract][Full Text] [Related]
24. Ribavirin monotherapy increases sustained response rate in relapsers of end treatment virologic responders.
Yen CL; Chang JJ; Lee TS; Liu CJ; Chen LW; Chang LC
World J Gastroenterol; 2005 Mar; 11(11):1663-7. PubMed ID: 15786546
[TBL] [Abstract][Full Text] [Related]
25. Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.
Bellobuono A; Mondazzi L; Tempini S; Silini E; Vicari F; Idéo G
J Viral Hepat; 1997 May; 4(3):185-91. PubMed ID: 9181527
[TBL] [Abstract][Full Text] [Related]
26. Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy.
Lo Iacono O; Castro A; Diago M; Moreno JA; Fernandez-Bermejo M; Vega P; García V; Carbonell P; Sanz P; Borque MJ; García-Buey L; García-Monzón C; Pedreira J; Moreno-Otero R
Aliment Pharmacol Ther; 2000 Apr; 14(4):463-9. PubMed ID: 10759626
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis C.
Dettmer RM; Reinus JF; Clain DJ; Aytaman A; Levendoglu H; Bloom AA; Isaacson MP; Spinnell M; Meyer D; Sarabanchong V; Zhang Y; Garcia-Carrasquillo RJ; Markowitz DD; Magun AM; Worman HJ
Hepatogastroenterology; 2002; 49(45):758-63. PubMed ID: 12063985
[TBL] [Abstract][Full Text] [Related]
28. Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.
Adinolfi LE; Utili R; Tonziello A; Ruggiero G
Gut; 2003 May; 52(5):701-5. PubMed ID: 12692056
[TBL] [Abstract][Full Text] [Related]
29. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.
Mazzaro C; Zorat F; Comar C; Nascimben F; Bianchini D; Baracetti S; Donada C; Donadon V; Pozzato G
J Rheumatol; 2003 Aug; 30(8):1775-81. PubMed ID: 12913934
[TBL] [Abstract][Full Text] [Related]
30. Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
Stauber RE; Hofer H; Hackl F; Schütze K; Datz C; Hegenbarth K; Jessner W; Steindl-Munda P; Peter F;
Wien Klin Wochenschr; 2004 Aug; 116(15-16):530-5. PubMed ID: 15471180
[TBL] [Abstract][Full Text] [Related]
31. High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.
Di Marco V; Vaccaro A; Ferraro D; Alaimo G; Rodolico V; Parisi P; Peralta S; Di Stefano R; Almasio PL; Craxì A
Aliment Pharmacol Ther; 2001 Jul; 15(7):953-8. PubMed ID: 11421869
[TBL] [Abstract][Full Text] [Related]
32. Firstline treatment for hepatitis C: combination interferon/ribavirin versus interferon monotherapy.
Lai MY
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E130-3. PubMed ID: 10921396
[TBL] [Abstract][Full Text] [Related]
33. Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone.
Puoti M; Cadeo GP; Putzolu V; Forleo MA; Barni MC; Cristini G; Rossi S; Spinetti A; Zaltron S; Zanini B; Quiros-Roldan E; Paraninfo G; Gargiulo F; Carosi G
Dig Liver Dis; 2001 Mar; 33(2):163-72. PubMed ID: 11346146
[TBL] [Abstract][Full Text] [Related]
34. Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials.
Kjaergard LL; Krogsgaard K; Gluud C
BMJ; 2001 Nov; 323(7322):1151-5. PubMed ID: 11711405
[TBL] [Abstract][Full Text] [Related]
35. Management of interferon relapsers.
Jacobson I
Am J Med; 1999 Dec; 107(6B):62S-66S. PubMed ID: 10653460
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of combination therapy with interferon-alfa plus ribavirin in patients with chronic hepatitis C virus infection: a single-center study in relapsers and nonresponders to previous treatment with high-dose interferon-alfa monotherapy.
Benini F; Distefano L; Baisini O; Pigozzi MG; Lanzini A
Curr Ther Res Clin Exp; 2003 Mar; 64(3):140-50. PubMed ID: 24944362
[TBL] [Abstract][Full Text] [Related]
37. Effect of interferon, ribavirin and ursodeoxycholic acid in patients with hepatitis C infection.
Ljubuncic P; Konikoff FM; Blendis LM; Bomzon A
Hepatogastroenterology; 2005; 52(64):1191-6. PubMed ID: 16001659
[TBL] [Abstract][Full Text] [Related]
38. Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: one year follow-up after 48 weeks of treatment.
Aladağ M; Karasu Z; Wright H; Gürakar A
Turk J Gastroenterol; 2006 Mar; 17(1):35-9. PubMed ID: 16830275
[TBL] [Abstract][Full Text] [Related]
39. Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C. A randomized, controlled pilot study.
Wenger C; Bischof T; Gonvers JJ; Renner EL; Mullhaupt B
Swiss Med Wkly; 2007 Jul; 137(29-30):418-23. PubMed ID: 17705104
[TBL] [Abstract][Full Text] [Related]
40. Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.
Steffen M; Cornberg M; Buggisch P
Hepatogastroenterology; 2007 Dec; 54(80):2368-72. PubMed ID: 18265667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
